Research suggests Twitter as a powerful tool to drive awareness about pancreatic cancer

A new study investigating pancreatic cancer-related Twitter conversations has found high rates of engagement among patients, advocates, and non-healthcare related individuals active in the pancreatic cancer space. 

Examining engagement with the pancreatic cancer Twitter chat, #PancChat, the study found one-in-five users (20 per cent) are patients, advocates, and non–health-care-related individuals. This suggests Twitter is an increasingly powerful tool to drive awareness among - and disseminate relevant healthcare information to - healthcare providers, patients, and caregivers.

The research was pioneered by UK-based specialist digital insights consultancy, Creation Healthcare, working in collaboration advocacy group Let’s Win! Pancreatic Cancer and leading medical professionals. The findings form part of a collaborative study published in March 2022 in the Journal of Medical Internet Research, a specialist digital health and open science journal. 

Using AI-driven software (Creation Pinpoint®), the study analysed 313,668 English-language unique mentions of pancreatic cancer on Twitter between January 2018 and December 2019, categorising each into one of five topic areas: 

  • Prevention (e.g. screening and awareness);
  • Survivorship
  • Treatment
  • Research
  • Policy (e.g. public health strategy).  

The researchers then further divided these into those generated by healthcare professionals (27,031) and those by the general public (307,449). 

Further potential

Despite the high rates of use among patients and the wider public, the research suggests healthcare professionals active in pancreatic cancer have yet to fully embrace the potential of social media to raise public awareness of key campaign objectives during periods of heightened interest.

As part of the analysis, the report investigated the impact of notable events in the online pancreatic cancer conversation, such as the pancreatic cancer-related deaths and diagnoses of high-profile public figures and Pancreatic Cancer Awareness Month.

The study found that despite heightened activity and interest among the general public during these periods, healthcare professionals were not initiating conversations online in key areas, such as risk factors, including a family history of pancreatic cancer.  

Pancreatic cancer awareness month 

Pancreatic Cancer Awareness Month, it found, was not driving online engagement among healthcare professionals across any of the five key topic areas. 

In contrast, online engagement among the general public was heightened during Pancreatic Cancer Awareness Month. However, this was only temporary and limited to just three of the five areas: treatment, research, and survivorship, not prevention or policy. 

High profile pancreatic cancer diagnoses and deaths

The study found that, typically, these announcements would not affect conversations initiated by healthcare professionals but had a varied impact on conversations among the general public.

After Alex Trebek, host of the television show Jeopardy, received his pancreatic cancer diagnosis in March 2019, public mentions of survivorship increased. Former Supreme Court Justice Ruth Bader Ginsburg’s diagnosis increased conversations on treatment in August 2019.

However, the announcement of American singer-songwriter Aretha Franklin’s death in August 2018 did not result in changes in any of the five domains studied as a part of the analysis. 

Overall 

The study found that, overall, the Twitter discussions of healthcare professionals were not aligned with discussions initiated by the public.  

Doctors most often discussed pancreatic cancer research (10,640/27,031 mentions, 39.4 per cent) while the public most often discussed treatment (154,484/307,449 mentions, 50.2 per cent). Policy drove the least engagement across both groups: 0.1 per cent of total mentions among healthcare professionals and 3.3 per cent among the public. The findings also showed healthcare professionals were more likely to initiate conversations related to research and prevention whereas the public took the lead in the domains of treatment and survivorship. 

Commenting on the findings, lead author of the report and Associate Director of Insight at Creation Healthcare, Jamie Doggett, said:

“The findings of this study are positive and significant. They indicate a high level of social media engagement in the pancreatic cancer conversation on Twitter among clinicians, patients, and the public. Healthcare professionals and advocacy groups can leverage this social media engagement to raise awareness and gain valuable feedback to create an ongoing loop. 

“The findings of the research also offer insight into how healthcare professionals and advocacy groups can optimise their digital engagement to further meet their broader campaign objectives, such as raising awareness regarding prevention, screening and early diagnosis.

“Stakeholders need to ensure conversations cover various attributes of pancreatic cancer care consistently, including preventative measures. Targeted tweets and conversations specifically related to pancreatic cancer may be essential in increasing discussions on cancer prevention and early identification. 

“More broadly, it showcases the growing role of social media in helping to build a realtime communicative and collaborative platform that allows healthcare providers to involve patients in their care by sharing the latest research and developments. 

“Ongoing analysis is also required. The information generated can be leveraged by stakeholders to design interventions to address deficiencies and improve communication in those specific areas in a focused manner. This knowledge will also add to the efficiency of targeted interventions such as tailored messaging, which may be used by healthcare organisations and advocacy groups to further augment dialogue around pancreatic cancer.” 

Commenting on the findings, fellow author of the study, Allyson J. Ocean, M.D. Chair, Scientific Advisory Board and Co-Founder of Let’s Win! Pancreatic Cancer, said:

“The findings of this study offer valuable insights for all stakeholder groups involved in the fight against pancreatic cancer, not least healthcare professionals.

“For one, they suggest healthcare professionals can harness Twitter to disseminate information to, and receive feedback from, a substantial community of patients and other relevant stakeholders.

“But, the data suggests there’s also more value to be gained from this online engagement platform. This is demonstrated by the lack of social media engagement among the medical community surrounding the deaths and diagnoses of high-profile public figures, such as Alex Trebek and Ruth Bader Ginsburg.

“We know from past experience that public figure cancer diagnoses have influenced public behaviour related to cancer. President Ronald Reagan’s diagnosis of colon cancer, for example, resulted in an increase in the number of colonoscopies performed on asymptomatic individuals.

“The medical community, particularly those involved in the treatment of and research into pancreatic cancer must do more to seize these opportunities to advance the healthcare communities priorities, such as awareness of symptoms and risk factors.”

Source:
Journal reference:

Grewal, U.S., et al. (2022) Twitter Conversations About Pancreatic Cancer by Health Care Providers and the General Public: Thematic Analysis. Journal of Medical Internet Research. doi.org/10.2196/31388.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists map cancer mutations in EGFR gene, revealing drug resistance paths